Medibank Private Limited
MDBPF · OTC
6/30/2025 | 12/30/2024 | 6/30/2024 | 12/30/2023 | |
|---|---|---|---|---|
| Revenue | $4 | $4 | $4 | $2 |
| % Growth | -5.2% | 11.1% | 93.5% | – |
| Cost of Goods Sold | $7 | $0 | $0 | $0 |
| Gross Profit | -$2 | $4 | $4 | $2 |
| % Margin | -60% | 100% | 99.5% | 100% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $1 | $0 | $0 | $0 |
| SG&A Expenses | $1 | $0 | $0 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | -$0 | -$0 |
| Operating Expenses | $1 | $0 | $0 | $0 |
| Operating Income | -$3 | $4 | $4 | $2 |
| % Margin | -80.4% | 92.9% | 92% | 92.6% |
| Other Income/Exp. Net | $4 | -$4 | -$3 | -$1 |
| Pre-Tax Income | $0 | $0 | $0 | $0 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | $0 | $0 | -$0 | $0 |
| % Margin | 3.9% | 7.8% | -8.6% | 16.8% |
| EPS | 0.06 | 0.12 | -0.12 | 0.12 |
| % Growth | -50% | 200% | -200% | – |
| EPS Diluted | 0.06 | 0.12 | -0.12 | 0.12 |
| Weighted Avg Shares Out | 3 | 3 | 3 | 3 |
| Weighted Avg Shares Out Dil | 3 | 3 | 3 | 3 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | $0 | $0 | $0 | $1 |
| % Margin | 8.1% | 11.4% | 7.1% | 26.2% |